|
Volumn 51, Issue 4, 2000, Pages 527-529
|
Potential cost savings from pill splitting of newer psychotropic medications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUSPIRONE;
DONEPEZIL;
FLUVOXAMINE MALEATE;
MIRTAZAPINE;
NEFAZODONE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PAROXETINE;
PSYCHOTROPIC AGENT;
QUETIAPINE;
RISPERIDONE;
SERTRALINE;
VENLAFAXINE;
ZOLPIDEM TARTRATE;
ARTICLE;
COST CONTROL;
DRUG COST;
DRUG EFFICACY;
MEDICAID;
MENTAL DISEASE;
PILL;
PSYCHOPHARMACOTHERAPY;
COST CONTROL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG COSTS;
HUMANS;
MENTAL DISORDERS;
PSYCHOTROPIC DRUGS;
|
EID: 0034117223
PISSN: 10752730
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ps.51.4.527 Document Type: Article |
Times cited : (18)
|
References (10)
|